Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Inecalcitol (Primary) ; Decitabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Hybrigenics
- 30 Jun 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 12 May 2017 According to a Hybrigenics media release, the company expects data from this trial in first half of 2019 (H119).
- 13 Sep 2016 According to a Hybrigenics media release, first patient has been enrolled in France.